Supporting cancer specialists by providing comprehensive characterization of a patient's cancer
At OncoDNA we strive to help cancer patients. OncoDNA offers solutions combining the most relevant molecular technologies in order to provide a comprehensive characterization of the patient’s cancer, hence supporting oncologists in their treatment and follow-up decisions.
Health Care Professionnals
OncoDNA provides theranostic solutions, supporting health care professionals in the complex process of selecting the best therapy for each cancer patient.
OncoDNA is pleased to announce collaboration in the MDLUX2 program from INC (National Cancer Institute), Molecular Diagnostics Program funded by IBBL (Integrated BioBank of Luxembourg), the Fondation Cancer and the Fondatioun Kriibskrank Kanner - English Version
OncoDNA annonce collaborer au lancement de MDLUX2 par l’INC (Institut National du Cancer), programme de diagnostic moléculaire financé par la Fondation Cancer, la Fondatioun Kriibskrank Kanner et IBBL (Integrated BioBank of Luxembourg). - Version Française